After decades of delays, biotechs hope that bacteria-attacking viruses could provide an alternative to traditional antibiotics.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Kingwell, K. Bacteriophage therapies re-enter clinical trials. Nat Rev Drug Discov 14, 515–516 (2015). https://doi.org/10.1038/nrd4695
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4695
- Springer Nature Limited
This article is cited by
-
Radiotherapy and the gut microbiome: facts and fiction
Radiation Oncology (2021)
-
Gut Microbiome over a Lifetime and the Association with Hypertension
Current Hypertension Reports (2021)
-
Manufacturing Stable Bacteriophage Powders by Including Buffer System in Formulations and Using Thin Film Freeze-drying Technology
Pharmaceutical Research (2021)
-
Blood pressure management in an ecosystem context
Hypertension Research (2020)
-
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications
Nature Reviews Gastroenterology & Hepatology (2019)